Center for LAM Research and Clinical Care
866-489-4056
Comprehensive care for lymphangioleiomyomatosis
We specialize in individualized care for women with lymphangioleiomyomatosis (LAM), addressing your unique needs through a comprehensive approach.
We are leaders in women's health and home to the nation's largest thoracic surgery center. Our participation in a global LAM research network gives you access to clinical trials that offer the latest advances in treatment. You also benefit from our dedicated team of specialists in urology, nutrition, OB/GYN, mental health, and reproductive medicine.
Our approach to LAM
LAM is a rare disease that causes abnormal muscle-like cells to grow uncontrollably, causing lung and kidney damage. It almost exclusively affects women.
Symptoms such as shortness of breath or a chronic cough usually begin in your 20s or 30s. Lung damage can lead to lung collapse or fluid in the chest. Over time, LAM can block airflow and reduce oxygen levels. LAM also causes benign kidney growths and enlarged lymph nodes.
There are two forms of LAM:
- TSC-associated LAM: Occurs in 30% to 40% of women with tuberous sclerosis complex (TSC)
- Sporadic LAM: Occurs in women who don't have TSC
LAM treatment focuses on managing your symptoms and preventing complications. Common treatments include:
- Inhalers to improve airflow
- Oxygen therapy and fluid removal to help you breathe
- Procedures to shrink kidney growths
- Lung transplant for advanced cases
Hormones like estrogen can make LAM worse. We recommend avoiding estrogen-based birth control.
Talk to your pulmonologist and OB/GYN if you're interested in getting pregnant. Pregnancy may be an option if you have normal lung function. We work closely with the Mass General Brigham reproductive medicine specialists to explore all your options safely.
Finding effective therapies for LAM is challenging. We connect women, doctors, and researchers to accelerate the development of clinical trials and find new treatments. Our research initiatives include:
- Developing new biomarkers to better predict how the disease progresses
- Creating a supply of LAM cells that the research community can use
- Pioneering a global network to share research data
- Using innovative clinical trial designs to test multiple drugs at one time and speed up drug testing
LAM conditions and treatments
Our specialists
866-489-4056
Contact the Center for LAM Research and Clinical Care
866-489-4056
International Patient Services
Contact information for international patients